サマリー

市場の展望
Triton Market Researchのレポートでは、中東とアフリカのセルライト治療市場は、予測年2023年から2030年の間に8.67％の複合年間成長率で前進すると考えられていることを意味しています。トルコ、サウジアラビア、南アフリカ、UAE、Rest of Middle East & Africaがこの地域の評価対象です。
アラブ首長国連邦では、化粧品や美容施術の技術的進歩が医療観光セクターを牽引しています。また、高齢化率の上昇も美容施術の需要を高め、メディカルツーリズムの成長に拍車をかけています。業界筋によると、国内の人口のうち65歳以上の高齢者がかなり多く、肌の引き締めやセルライト除去のニーズが急増している。このような要因が、セルライト治療市場の拡大に拍車をかけています。
さらに、トルコでは、外見を美しくしたいという消費者ニーズの高まりから、近年、美容整形手術の需要が急増しています。このため、美容整形を提供する医療機関の数も加速しています。さらに、熟練した専門家の増加や技術の進歩により、肥満と診断された患者を治療するためのセルライト除去治療の需要が生まれると予想されます。したがって、上記のすべての要因は、セルライト治療市場の範囲を広げると予測されます。

競争展望
セルライト治療市場の有名企業は、Bausch Health Companies Inc、Inceler Medikal、Sientra Inc、Endo International Plc、およびCandela Medical Corporationで構成されています。

ページTOPに戻る

目次

TABLE OF CONTENTS
1. MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PARENT MARKET ANALYSIS
2.2. IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1. COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2. UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET MATURITY ANALYSIS
2.5. INDUSTRY COMPONENTS
2.5.1. RESEARCH AND DEVELOPMENT
2.5.2. MANUFACTURING OF PRODUCT
2.5.3. DISTRIBUTION
2.5.4. POST-SALES MONITORING
2.6. REGULATORY FRAMEWORK
2.7. KEY BUYING IMPACT ANALYSIS
2.7.1. PRICE
2.7.2. BRAND NAME
2.7.3. USABILITY
2.8. KEY MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. MERGERS & ACQUISITIONS
2.8.4. BUSINESS DIVESTITURES & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. GROWING PREVALENCE OF OBESITY
2.9.2. RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3. RISING DEMAND FOR AESTHETIC PROCEDURES
2.10. MARKET CHALLENGES
2.10.1. LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2. HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3. RISKS ASSOCIATED POST-TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. RISING BEAUTY CONSCIOUSNESS
2.11.2. INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3. GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4. RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5. ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12. ANALYST PERSPECTIVE
3. MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1. SOFT CELLULITE
3.2. HARD CELLULITE
3.3. EDEMATOUS CELLULITE
4. MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1. NON-INVASIVE
4.2. MINIMALLY INVASIVE
4.3. TOPICAL
5. MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS AND BEAUTY CENTERS
5.3. OTHER END-USERS
6. MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1. COUNTRY ANALYSIS
6.1.1. UNITED ARAB EMIRATES
6.1.1.1. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2. TURKEY
6.1.2.1. TURKEY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3. SAUDI ARABIA
6.1.3.1. SAUDI ARABIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4. SOUTH AFRICA
6.1.4.1. SOUTH AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5. REST OF MIDDLE EAST & AFRICA
6.1.5.1. REST OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1. JOHNSON & JOHNSON
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY STRENGTHS
7.1.4. KEY CHALLENGES
7.2. ABBVIE INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY STRENGTHS
7.2.4. KEY CHALLENGES
7.3. BAUSCH HEALTH COMPANIES INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY STRENGTHS
7.3.4. KEY CHALLENGES
7.4. CUTERA INC
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY STRENGTHS
7.4.4. KEY CHALLENGES
7.5. INCELER MEDIKAL
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY STRENGTHS
7.5.4. KEY CHALLENGES
7.6. ZIMMER MEDIZINSYSTEME GMBH
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY STRENGTHS
7.6.4. KEY CHALLENGES
7.7. GALDERMA SA
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY STRENGTHS
7.7.4. KEY CHALLENGES
7.8. SIENTRA INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY CHALLENGES
7.9. ENDO INTERNATIONAL PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY STRENGTHS
7.9.4. KEY CHALLENGES
7.10. CANDELA MEDICAL CORPORATION
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF THE PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: TURKEY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: SAUDI ARABIA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: SOUTH AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: REST OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る

図表リスト

TABLE LIST
TABLE 1: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)